MAPT and Alzheimer disease: Pathologically, the majority of individuals have frontotemporal lobar degeneration (FTLD) with inclusions containing tau or transactive response DNA binding protein 43 (TDP-43), although some, particularly those with the logopenic variant of PPA (lvPPA), have Alzheimer’s disease (AD) pathology [2].